How merchandising and layout of Ikea influence the consumer behavior?

This dissertation is a company’s project focused on marketing, merchandising and consumer behavior areas adapted to Ikea. The consumer behavior is studied very often and approached by many perspectives. The marketing strategy and tools used can have great influence on the image that the customer has about the company. The visual communication strategy defined by the company is crucial to pass the message. The main focus in this study is to see how merchandising and store layout influence customer behavior, specifically in Ikea stores. In order to understand consumer’s perceptions, it was necessary to conduct a survey where were tested many aspects of the Ikea’s Marketing and store experience. The conclusion is that Ikea has a very powerful marketing presence to the consumer and all the in-store variables have a positive effect on consumer. In the end it is recommended to develop the digital connection with the consumer. The second recommendation is about the store design, it is suggested to make a long and a shorter path, to customers who know what they want. The third recommendation consists on an elaboration of virtual showrooms in the stores, where the customer can see different cinereums in the same place, giving opportunity to store more material. The fourth recommendation is the execution of premium class products, and also a customized product class.Esta tese é um projeto empresa focado nas áreas de marketing, merchandising e comportamento do consumidor adaptadas à Ikea. O comportamento do consumidor é estudado com muita frequência e abordado por muitas perspectivas devido à sua elevada importância. A estratégia e ferramentas de marketing utilizadas podem ter grande influência na imagem que o cliente tem da empresa, assim como a estratégia de comunicação visual definida é crucial para divulgar a mensagem. O foco principal deste estudo é analisar como o merchandising e o layout da loja influenciam o comportamento do cliente, especificamente nas lojas Ikea. Deste modo, é pertinente entender se o layout da loja e as caraterísticas de loja são adequados para um cliente cada vez mais exigente. Para entender as perceções dos consumidores, foram testados muitos aspetos da experiência de marketing e loja da Ikea. Após a análise dos resultados conclui-se que a Ikea tem uma presença de marketing bastante vincada para o consumidor e quase todas as variáveis da loja têm um efeito positivo no consumidor. Por fim, foram apresentadas algumas sugestões como: desenvolver a conexão digital com o consumidor; A segunda recomendação consiste numa alteração no design da loja: nesta ótica pretende-se atender à necessidade da criação de um caminho mais curto e prático para visitar a loja; A terceira recomendação consiste na elaboração de showrooms virtuais nas lojas, dando a oportunidade de armazenar mais material; A quarta recomendação é a execução de produtos de classe premium e ainda elaboração de uma classe de produtos personalizada

A robótica educacional no ensino de Química, elaboração, construção e aplicação de um robô imóvel no ensino de conceitos relacionados à tabela periódica

ESSE TRABALHA APRESENTA A ELABORAÇÃO, DESENVOLVIMENTO E APLICAÇÃO DE UM ROBÔ DO TIPO IMÓVEL, CHAMADO ROBÔ IMÓVEL TABELA PERIÓDICA (RITP). O RESULTADO É UMA TABELA PERIÓDICA INTERATIVA QUE PRETENDE OFERECER AO PROFESSOR A OPORTUNIDADE DE ORIENTAR OS ALUNOS A CONSTRUIR O CONCEITO DE FORMA CONJUNTA, DESENVOLVENDO-O A PARTIR DE INFORMAÇÕES FUNDAMENTAIS QUE ENVOLVEM CONCEITOS BÁSICOS DAS DIFERENTES ÁREAS DO CONHECIMENTO, SENDO ELES QUÍMICOS, FÍSICOS E MATEMÁTICOS E DE LÓGICA COMPUTACIONAL. O RITP FOI DESENVOLVIDO EM 6 MESES, UTILIZANDO MATERIAIS DE FÁCIL ACESSO E DE BAIXO CUSTO. SUA INTERFACE PODE SER CONTROLADA POR UM SOFTWARE LIVRE, CHAMADO LOGO. NOTAMOS NO TRABALHO QUE O RITP PODE PROPORCIONAR UMA NOVA FORMA DE AVALIAR OS ALUNOS, CRIANDO UM AMBIENTE DESCONTRAÍDO E DE COOPERAÇÃO PARA QUE OS ESTUDANTES POSSAM SE DIVERTIR EM GRUPOS, EXPLORANDO AS POTENCIALIDADES PRESENTES NA ROBÓTICA EDUCACIONAL

Influenza severe cases in hospitals, between 2014 and 2016 in Portugal

Rede Portuguesa de Laboratórios para o Diagnóstico da GripeBackground: Since 2009, the Portuguese Laboratory Network (PLNID) for Influenza Diagnosis has integrated 15 Laboratories in mainland and Atlantic Islands of Azores and Madeira. This PLNID added an important contribute to the National Influenza Surveillance Program regarding severe and hospitalized influenza cases. The present study aims to describe influenza viruses detected in influenza like illness (ILI) cases: outpatients (Outp), hospitalized (Hosp), and intensive care units (ICU), between 2014 and 2016. Methods: The PLNID performs influenza virus diagnosis by biomolecular methodologies. Weekly reports to the National Influenza Reference Laboratory ILI cases tested for influenza. Reports include data on detecting viruses, hospital assistance, antiviral therapeutics, and information on death outcome. Were reported during two winter seasons 8059 ILI cases,being 3560 cases in 2014/15 (1024 in Outp, 1750 Hosp, and 606 in ICU) and 4499 cases in 2015/2016 (1933 in Outp, 1826 Hosp, and 740 in ICU). Results: The higher percentage of influenza positive cases were detected in Outp in both seasons, 18% during 2014/15 and 20% in 2015/16. In 2014/15,influenza cases were more frequent in individuals older than 65 years old and these required more hospitalizations,even in ICU. In 2015/16,the influenza cases were mainly detected in individuals between 15-64 years old. A higher proportion of influenza positive cases with hospitalization in ICU were observed in adults between 45-64 years old.During the study period,the predominant circulating influenza viruses were different in the two seasons: influenza B and A(H3) co-circulated in 2014/15,and influenza A(H1)pdm09 was predominant during 2015/16. Even when influenza A is notthe dominant virus, A(H3) and A(H1)pdm09 subtypes correlate with higher detection rate in hospitalized cases (Hosp and UCI), with higher frequencies in adults older than 45. Influenza B,detected in higher proportion in outpatients, was frequently relatedwith influenza cases in younger age groups: 0-4 and 5-14 years old. Conclusions: This study highlights the correlation of theinfluenza virus type/subtype that circulates in each season with the possible need for hospitalization and intensive care in special groups of the population. Circulation of influenza A subtypes can cause more frequentdisease in individuals older than 45, with need of hospitalization including intensive care. On the other hand, influenza B is more frequently associated with less severe cases and with infection in children and younger adults. Influenza B circulation might predict lower number of hospitalizations.The identification of influenza type in circulation,byPLNID ineach season, could guide action planning measures in population health care.info:eu-repo/semantics/publishedVersio

Nationwide access to endovascular treatment for acute ischemic stroke in portugal

Publisher Copyright: Copyright Ordem dos M dicos 2021.Introduction: Since the publication of endovascular treatment trials and European Stroke Guidelines, Portugal has re-organized stroke healthcare. The nine centers performing endovascular treatment are not equally distributed within the country, which may lead to differential access to endovascular treatment. Our main aim was to perform a descriptive analysis of the main treatment metrics regarding endovascular treatment in mainland Portugal and its administrative districts. Material and Methods: A retrospective national multicentric cohort study was conducted, including all ischemic stroke patients treated with endovascular treatment in mainland Portugal over two years (July 2015 to June 2017). All endovascular treatment centers contributed to an anonymized database. Demographic, stroke-related and procedure-related variables were collected. Crude endovascular treatment rates were calculated per 100 000 inhabitants for mainland Portugal, and each district and endovascular treatment standardized ratios (indirect age-sex standardization) were also calculated. Patient time metrics were computed as the median time between stroke onset, first-door, and puncture. Results: A total of 1625 endovascular treatment procedures were registered. The endovascular treatment rate was 8.27/100 000 inhabitants/year. We found regional heterogeneity in endovascular treatment rates (1.58 to 16.53/100 000/year), with higher rates in districts closer to endovascular treatment centers. When analyzed by district, the median time from stroke onset to puncture ranged from 212 to 432 minutes, reflecting regional heterogeneity. Discussion: Overall endovascular treatment rates and procedural times in Portugal are comparable to other international registries. We found geographic heterogeneity, with lower endovascular treatment rates and longer onset-to-puncture time in southern and inner regions. Conclusion: The overall national rate of EVT in the first two years after the organization of EVT-capable centers is one of the highest among European countries, however, significant regional disparities were documented. Moreover, stroke-onset-to-first-door times and in-hospital procedural times in the EVT centers were comparable to those reported in the randomized controlled trials performed in high-volume tertiary hospitalspublishersversionpublishe

SÍNDROME HEMOLÍTICO-URÊMICA NA PEDIATRIA E SUAS COMPLICAÇÕES: ANÁLISE DE CASOS

Hemolytic-Uremic Syndrome (HUS) is a serious disease characterized by the classic triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.  This research is a systematic literature review, of a quantitative nature, which used the platforms PubMed, Scientific Electronic Library On-line (SciELO) and Google Scholar as a database to search for scientific articles.  The choice of articles to be used in this review was performed by reading the title, abstract and, finally, reading the article in its entirety, with a careful analysis of the articles based on the aforementioned inclusion and exclusion criteria.  The pathogenesis of HUS corresponds to a thrombotic microangiopathy, with a poor prognosis, and the diagnosis is usually made from the exclusion of other diseases.  In the first clinical manifestation of the disease, almost half of the patients evolve to death or progress to end-stage renal disease.  The treatment has the use of the drug Eculizumab, which has a high cost, but increases the expectation and quality of life of these patients.  Thus, further studies on this disease are necessary for the development of new diagnostic measures and therapies.El síndrome urémico hemolítico (SUH) es una enfermedad grave caracterizada por la tríada clásica de anemia hemolítica microangiopática, trombocitopenia e insuficiencia renal aguda. Esta investigación es una revisión bibliográfica sistemática de carácter cuantitativo, que utilizó las plataformas PubMed, Scientific Electronic Library Online (SciELO) y Google Scholar como base de datos para la investigación de artículos científicos. La elección de los artículos a utilizar en esta revisión se realizó mediante la lectura del título, el resumen y, finalmente, la lectura completa del artículo, y se realizó un análisis cuidadoso de los artículos basado en los criterios de inclusión y exclusión mencionados anteriormente. La patogénesis del SUH corresponde a una microangiopatía trombótica, presentando un mal pronóstico, y el diagnóstico se suele realizar a partir de la exclusión de otras enfermedades. En la primera manifestación clínica de la enfermedad, casi la mitad de los pacientes progresan a la muerte o progresan a la enfermedad renal crónica en etapa terminal. El tratamiento cuenta con el uso del fármaco Eculizumab, que presenta un alto costo, pero aumenta la expectativa y calidad de vida de estos pacientes. Por lo tanto, se necesitan más estudios sobre esta enfermedad para el desarrollo de nuevas medidas diagnósticas y terapias.A Síndrome Hemolítico-Urêmica (SHU) é uma doença grave, caracterizada pela tríade clássica de anemia hemolítica microangiopática, trombocitopenia e insuficiência renal aguda. Esta pesquisa trata-se de uma revisão bibliográfica sistemática, de natureza quantitativa, que utilizou as plataformas PubMed, Scientific Eletronic Library On-line (SciELO) e Google Scholar como base de dados para pesquisa dos artigos científicos. A escolha dos artigos a serem utilizados nesta revisão foi realizada por meio da leitura do título, resumo e, por fim, da leitura do artigo na íntegra, sendo realizada uma análise criteriosa dos artigos fundamentados nos critérios de inclusão e exclusão supracitados. A patogênese da SHU corresponde a uma microangiopatia trombótica, apresentando um prognóstico ruim, sendo o diagnóstico realizado geralmente a partir de exclusão de outras doenças. Na primeira manifestação clínica da doença, quase metade dos pacientes evoluem ao óbito ou progridem para doença renal crônica terminal. O tratamento possui a utilização do fármaco Eculizumab, o qual apresenta um alto custo, porém a aumenta a expectativa e a qualidade de vida desses pacientes. Com isso, mais estudos acerca desta doença são necessários para o desenvolvimento de novas medidas de diagnóstico e terapias

SÍNDROME HEMOLÍTICO-URÊMICA NA PEDIATRIA E SUAS COMPLICAÇÕES: ANÁLISE DE CASOS

Hemolytic-Uremic Syndrome (HUS) is a serious disease characterized by the classic triad of microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.  This research is a systematic literature review, of a quantitative nature, which used the platforms PubMed, Scientific Electronic Library On-line (SciELO) and Google Scholar as a database to search for scientific articles.  The choice of articles to be used in this review was performed by reading the title, abstract and, finally, reading the article in its entirety, with a careful analysis of the articles based on the aforementioned inclusion and exclusion criteria.  The pathogenesis of HUS corresponds to a thrombotic microangiopathy, with a poor prognosis, and the diagnosis is usually made from the exclusion of other diseases.  In the first clinical manifestation of the disease, almost half of the patients evolve to death or progress to end-stage renal disease.  The treatment has the use of the drug Eculizumab, which has a high cost, but increases the expectation and quality of life of these patients.  Thus, further studies on this disease are necessary for the development of new diagnostic measures and therapies.El síndrome urémico hemolítico (SUH) es una enfermedad grave caracterizada por la tríada clásica de anemia hemolítica microangiopática, trombocitopenia e insuficiencia renal aguda. Esta investigación es una revisión bibliográfica sistemática de carácter cuantitativo, que utilizó las plataformas PubMed, Scientific Electronic Library Online (SciELO) y Google Scholar como base de datos para la investigación de artículos científicos. La elección de los artículos a utilizar en esta revisión se realizó mediante la lectura del título, el resumen y, finalmente, la lectura completa del artículo, y se realizó un análisis cuidadoso de los artículos basado en los criterios de inclusión y exclusión mencionados anteriormente. La patogénesis del SUH corresponde a una microangiopatía trombótica, presentando un mal pronóstico, y el diagnóstico se suele realizar a partir de la exclusión de otras enfermedades. En la primera manifestación clínica de la enfermedad, casi la mitad de los pacientes progresan a la muerte o progresan a la enfermedad renal crónica en etapa terminal. El tratamiento cuenta con el uso del fármaco Eculizumab, que presenta un alto costo, pero aumenta la expectativa y calidad de vida de estos pacientes. Por lo tanto, se necesitan más estudios sobre esta enfermedad para el desarrollo de nuevas medidas diagnósticas y terapias.A Síndrome Hemolítico-Urêmica (SHU) é uma doença grave, caracterizada pela tríade clássica de anemia hemolítica microangiopática, trombocitopenia e insuficiência renal aguda. Esta pesquisa trata-se de uma revisão bibliográfica sistemática, de natureza quantitativa, que utilizou as plataformas PubMed, Scientific Eletronic Library On-line (SciELO) e Google Scholar como base de dados para pesquisa dos artigos científicos. A escolha dos artigos a serem utilizados nesta revisão foi realizada por meio da leitura do título, resumo e, por fim, da leitura do artigo na íntegra, sendo realizada uma análise criteriosa dos artigos fundamentados nos critérios de inclusão e exclusão supracitados. A patogênese da SHU corresponde a uma microangiopatia trombótica, apresentando um prognóstico ruim, sendo o diagnóstico realizado geralmente a partir de exclusão de outras doenças. Na primeira manifestação clínica da doença, quase metade dos pacientes evoluem ao óbito ou progridem para doença renal crônica terminal. O tratamento possui a utilização do fármaco Eculizumab, o qual apresenta um alto custo, porém a aumenta a expectativa e a qualidade de vida desses pacientes. Com isso, mais estudos acerca desta doença são necessários para o desenvolvimento de novas medidas de diagnóstico e terapias

Acesso a Tratamento Endovascular para Acidente Vascular Cerebral Isquémico em Portugal

Introduction: Since the publication of endovascular treatment trials and European Stroke Guidelines, Portugal has re-organized stroke healthcare. The nine centers performing endovascular treatment are not equally distributed within the country, which may lead to differential access to endovascular treatment. Our main aim was to perform a descriptive analysis of the main treatment metrics regarding endovascular treatment in mainland Portugal and its administrative districts. Material and Methods: A retrospective national multicentric cohort study was conducted, including all ischemic stroke patients treated with endovascular treatment in mainland Portugal over two years (July 2015 to June 2017). All endovascular treatment centers contributed to an anonymized database. Demographic, stroke-related and procedure-related variables were collected. Crude endovascular treatment rates were calculated per 100 000 inhabitants for mainland Portugal, and each district and endovascular treatment standardized ratios (indirect age-sex standardization) were also calculated. Patient time metrics were computed as the median time between stroke onset, first-door, and puncture. Results: A total of 1625 endovascular treatment procedures were registered. The endovascular treatment rate was 8.27/100 000 inhabitants/year. We found regional heterogeneity in endovascular treatment rates (1.58 to 16.53/100 000/year), with higher rates in districts closer to endovascular treatment centers. When analyzed by district, the median time from stroke onset to puncture ranged from 212 to 432 minutes, reflecting regional heterogeneity. Conclusion: The overall national rate of EVT in the first two years after the organization of EVT-capable centers is one of the highest among European countries, however, significant regional disparities were documented. Moreover, stroke-onset-to-first-door times and in-hospital procedural times in the EVT centers were comparable to those reported in the randomized controlled trials performed in high-volume tertiary hospitals.Introdução: A aprovação do tratamento endovascular para o acidente vascular cerebral isquémico obrigou à reorganização dos cuidados de saúde em Portugal. Os nove centros que realizam tratamento endovascular não estão distribuídos equitativamente pelo território, o que poderá causar acesso diferencial a tratamento. O principal objetivo deste estudo é realizar uma análise descritiva da frequência e métricas temporais do tratamento endovascular em Portugal continental e seus distritos. Material e Métodos: Estudo de coorte nacional multicêntrico, incluindo todos os doentes com acidente vascular cerebral isquémico submetidos a tratamento endovascular em Portugal continental durante um período de dois anos (julho 2015 a junho 2017). Foram colhidos dados demográficos, relacionados com o acidente vascular cerebral e variáveis do procedimento. Taxas de tratamento endovascular brutas e ajustadas (ajuste indireto a idade e sexo) foram calculadas por 100 000 habitantes/ano para Portugal continental e cada distrito. Métricas de procedimento como tempo entre instalação, primeira porta e punção foram também analisadas. Resultados: Foram registados 1625 tratamentos endovasculares, indicando uma taxa bruta nacional de tratamento endovascular de 8,27/100 000 habitantes/ano. As taxas de tratamento endovascular entre distritos variaram entre 1,58 e 16,53/100 000/ano, com taxas mais elevadas nos distritos próximos a hospitais com tratamento endovascular. O tempo entre sintomas e punção femural entre distritos variou entre 212 e 432 minutos. Conclusão: Portugal continental apresenta uma taxa nacional de tratamento endovascular elevada, apresentando, contudo, assimetrias regionais no acesso. As métricas temporais foram comparáveis com as observadas nos ensaios clínicos piloto

SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal

Genomic surveillance of SARS-CoV-2 in Portugal was rapidly implemented by the National Institute of Health in the early stages of the COVID-19 epidemic, in collaboration with more than 50 laboratories distributed nationwide. Methods By applying recent phylodynamic models that allow integration of individual-based travel history, we reconstructed and characterized the spatio-temporal dynamics of SARSCoV-2 introductions and early dissemination in Portugal. Results We detected at least 277 independent SARS-CoV-2 introductions, mostly from European countries (namely the United Kingdom, Spain, France, Italy, and Switzerland), which were consistent with the countries with the highest connectivity with Portugal. Although most introductions were estimated to have occurred during early March 2020, it is likely that SARS-CoV-2 was silently circulating in Portugal throughout February, before the first cases were confirmed. Conclusions Here we conclude that the earlier implementation of measures could have minimized the number of introductions and subsequent virus expansion in Portugal. This study lays the foundation for genomic epidemiology of SARS-CoV-2 in Portugal, and highlights the need for systematic and geographically-representative genomic surveillance.We gratefully acknowledge to Sara Hill and Nuno Faria (University of Oxford) and Joshua Quick and Nick Loman (University of Birmingham) for kindly providing us with the initial sets of Artic Network primers for NGS; Rafael Mamede (MRamirez team, IMM, Lisbon) for developing and sharing a bioinformatics script for sequence curation (https://github.com/rfm-targa/BioinfUtils); Philippe Lemey (KU Leuven) for providing guidance on the implementation of the phylodynamic models; Joshua L. Cherry (National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health) for providing guidance with the subsampling strategies; and all authors, originating and submitting laboratories who have contributed genome data on GISAID (https://www.gisaid.org/) on which part of this research is based. The opinions expressed in this article are those of the authors and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the United States government. This study is co-funded by Fundação para a Ciência e Tecnologia and Agência de Investigação Clínica e Inovação Biomédica (234_596874175) on behalf of the Research 4 COVID-19 call. Some infrastructural resources used in this study come from the GenomePT project (POCI-01-0145-FEDER-022184), supported by COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Lisboa Portugal Regional Operational Programme (Lisboa2020), Algarve Portugal Regional Operational Programme (CRESC Algarve2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), and by Fundação para a Ciência e a Tecnologia (FCT).info:eu-repo/semantics/publishedVersio

Isolamento

info:eu-repo/semantics/publishedVersio

A list of land plants of Parque Nacional do Caparaó, Brazil, highlights the presence of sampling gaps within this protected area

Brazilian protected areas are essential for plant conservation in the Atlantic Forest domain, one of the 36 global biodiversity hotspots. A major challenge for improving conservation actions is to know the plant richness, protected by these areas. Online databases offer an accessible way to build plant species lists and to provide relevant information about biodiversity. A list of land plants of “Parque Nacional do Caparaó” (PNC) was previously built using online databases and published on the website "Catálogo de Plantas das Unidades de Conservação do Brasil." Here, we provide and discuss additional information about plant species richness, endemism and conservation in the PNC that could not be included in the List. We documented 1,791 species of land plants as occurring in PNC, of which 63 are cited as threatened (CR, EN or VU) by the Brazilian National Red List, seven as data deficient (DD) and five as priorities for conservation. Fifity-one species were possible new ocurrences for ES and MG states